I would posit that the continuing uncertainty over Garner's selling off, MOF's commitment and whether it truly aligns with us LT holders and the inability of the Australian market to correctly value biotechs to be of ongoing concern to holders, both short and long term.
I ask the question of Daniel in his capacity as our largest shareholder. Perhaps I can clarify that angle with future questions. But it's an anxiety worth discussing. Dr T is free to decline a response. And we are free to discern as much information as possible.
RAC - Charts & Price Action, page-9352
-
- There are more pages in this discussion • 13,589 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
0.085(5.80%) |
Mkt cap ! $264.2M | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.55 | $1.49 | $246.4K | 163.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 5483 | 2 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |